Review



p akt dyc887b 2 kits  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems p akt dyc887b 2 kits
    P Akt Dyc887b 2 Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Phospho-Akt+(S473)+Pan+Specific+DuoSet+IC+ELISA/pm41760328-115-5-11
    Average 94 stars, based on 28 article reviews
    p akt dyc887b 2 kits - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
    Article Snippet: .. The Pan AKT-specific ELISA kit (R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany, No. DYC887B-5) was used for quantification of phospho-AKT S473 according to the manufacturer's protocol with the following modifications: After the incubation with a biotinylated phospho-AKT (S473) panspecific detection antibody (1:180), we used an alkaline phosphatase–conjugated streptavidin SA110 (Millipore, Schwalbach, Germany) (1:4000) at room temperature. .. For fluorometric detection of alkaline phosphatase, AttoPhos substrate set (Roche Diagnostics GmbH, Mannheim, Germany) was used (100 μl per well).

    Article Title: Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
    Article Snippet: .. Phospho-AKT S473 ELISA The Pan AKT-specific ELISA kit (R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany, No. DYC887B-5) was used for quantification of phospho-AKT S473 according to the manufacturer's protocol with the following modifications: After the incubation with a biotinylated phospho-AKT (S473) panspecific detection antibody (1:180), we used an alkaline phosphatase–conjugated streptavidin SA110 (Millipore, Schwalbach, Germany) (1:4000) at room temperature. .. For fluorometric detection of alkaline phosphatase, AttoPhos substrate set (Roche Diagnostics GmbH, Mannheim, Germany) was used (100 μl per well).

    Incubation:

    Article Title: Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
    Article Snippet: .. The Pan AKT-specific ELISA kit (R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany, No. DYC887B-5) was used for quantification of phospho-AKT S473 according to the manufacturer's protocol with the following modifications: After the incubation with a biotinylated phospho-AKT (S473) panspecific detection antibody (1:180), we used an alkaline phosphatase–conjugated streptavidin SA110 (Millipore, Schwalbach, Germany) (1:4000) at room temperature. .. For fluorometric detection of alkaline phosphatase, AttoPhos substrate set (Roche Diagnostics GmbH, Mannheim, Germany) was used (100 μl per well).

    Article Title: Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
    Article Snippet: .. Phospho-AKT S473 ELISA The Pan AKT-specific ELISA kit (R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany, No. DYC887B-5) was used for quantification of phospho-AKT S473 according to the manufacturer's protocol with the following modifications: After the incubation with a biotinylated phospho-AKT (S473) panspecific detection antibody (1:180), we used an alkaline phosphatase–conjugated streptavidin SA110 (Millipore, Schwalbach, Germany) (1:4000) at room temperature. .. For fluorometric detection of alkaline phosphatase, AttoPhos substrate set (Roche Diagnostics GmbH, Mannheim, Germany) was used (100 μl per well).



    Similar Products

    90
    Bio-Techne corporation phospho-akt (s473) pan specific duoset ic elisa kits (cat. #.
    a LNP cellular uptake measured by flow cytometry: Internalization of Rhodamine R18-labeled MO cubosomes (10 µM) in differentiated SH-SY5Y cells after 24 h of incubation (determined by FL2 fluorescence intensity). b Cellular uptake of PACAP: Internalization of PACAP-TAMRA (5 µM) in differentiated SH-SY5Y cells at different incubation times of 3 h, 6 h and 24 h (determined by FL2 fluorescence intensity). c Cellular uptake of LNP-PACAP: Internalization of LNP-PACAP-TAMRA by differentiated SH-SY5Y cells from 5 µM PACAP-TAMRA/10 µM LNPs mixture at different time points 3 h, 6 h and 24 h. The data of ( a – c ) was presented as a ratio of the mean intensity of FL2 in the treated group ( n = 3) and the mean intensity of FL2 in the RA/FBS(-) control group. d Kinetic changes of CREB phosphorylation in the PD model. The <t>ELISA</t> assay was performed with plasmalogen-loaded PL-C LNPs, which were dispersed at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The different incubation times were 0, 3 h, 6 h, and 24 h following 30 min 6-OHDA exposure. e Kinetics changes of <t>phospho-AKT</t> expression levels in the treated PD model. ELISA assay was performed with plasmalogen-loaded nanoparticles PL-C, which were dispersed at same total lipid concentration of 10 µM in the presence of 5 µM PACAP. f Kinetic changes of phospho-ERK expression in the treated PD model measured by ELISA assay with plasmalogen-loaded nanoparticles PL-C at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The data of ( d – f ) is presented as a ratio of the quantity of p-CREB, p-AKT or p-ERK expression (ng) per total protein (ng) in the treated group ( n = 3) and the quantity of p-CREB expression (ng) per total protein (ng) in the 6-OHDA group ( n = 3). n indicates the number of replicates per group and the error bars represent the standard deviation. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.
    Phospho Akt (S473) Pan Specific Duoset Ic Elisa Kits (Cat. #., supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Human+Aminopeptidase+N%2FCD13+DuoSet+ELISA/pmc10628290-364-6-1
    Average 90 stars, based on 1 article reviews
    phospho-akt (s473) pan specific duoset ic elisa kits (cat. #. - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    R&D Systems p akt dyc887b 2 kits
    a LNP cellular uptake measured by flow cytometry: Internalization of Rhodamine R18-labeled MO cubosomes (10 µM) in differentiated SH-SY5Y cells after 24 h of incubation (determined by FL2 fluorescence intensity). b Cellular uptake of PACAP: Internalization of PACAP-TAMRA (5 µM) in differentiated SH-SY5Y cells at different incubation times of 3 h, 6 h and 24 h (determined by FL2 fluorescence intensity). c Cellular uptake of LNP-PACAP: Internalization of LNP-PACAP-TAMRA by differentiated SH-SY5Y cells from 5 µM PACAP-TAMRA/10 µM LNPs mixture at different time points 3 h, 6 h and 24 h. The data of ( a – c ) was presented as a ratio of the mean intensity of FL2 in the treated group ( n = 3) and the mean intensity of FL2 in the RA/FBS(-) control group. d Kinetic changes of CREB phosphorylation in the PD model. The <t>ELISA</t> assay was performed with plasmalogen-loaded PL-C LNPs, which were dispersed at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The different incubation times were 0, 3 h, 6 h, and 24 h following 30 min 6-OHDA exposure. e Kinetics changes of <t>phospho-AKT</t> expression levels in the treated PD model. ELISA assay was performed with plasmalogen-loaded nanoparticles PL-C, which were dispersed at same total lipid concentration of 10 µM in the presence of 5 µM PACAP. f Kinetic changes of phospho-ERK expression in the treated PD model measured by ELISA assay with plasmalogen-loaded nanoparticles PL-C at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The data of ( d – f ) is presented as a ratio of the quantity of p-CREB, p-AKT or p-ERK expression (ng) per total protein (ng) in the treated group ( n = 3) and the quantity of p-CREB expression (ng) per total protein (ng) in the 6-OHDA group ( n = 3). n indicates the number of replicates per group and the error bars represent the standard deviation. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.
    P Akt Dyc887b 2 Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Phospho-Akt+(S473)+Pan+Specific+DuoSet+IC+ELISA/pm41760328-115-5-11
    Average 94 stars, based on 1 article reviews
    p akt dyc887b 2 kits - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    R&D Systems duoset ic elisa kit
    a LNP cellular uptake measured by flow cytometry: Internalization of Rhodamine R18-labeled MO cubosomes (10 µM) in differentiated SH-SY5Y cells after 24 h of incubation (determined by FL2 fluorescence intensity). b Cellular uptake of PACAP: Internalization of PACAP-TAMRA (5 µM) in differentiated SH-SY5Y cells at different incubation times of 3 h, 6 h and 24 h (determined by FL2 fluorescence intensity). c Cellular uptake of LNP-PACAP: Internalization of LNP-PACAP-TAMRA by differentiated SH-SY5Y cells from 5 µM PACAP-TAMRA/10 µM LNPs mixture at different time points 3 h, 6 h and 24 h. The data of ( a – c ) was presented as a ratio of the mean intensity of FL2 in the treated group ( n = 3) and the mean intensity of FL2 in the RA/FBS(-) control group. d Kinetic changes of CREB phosphorylation in the PD model. The <t>ELISA</t> assay was performed with plasmalogen-loaded PL-C LNPs, which were dispersed at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The different incubation times were 0, 3 h, 6 h, and 24 h following 30 min 6-OHDA exposure. e Kinetics changes of <t>phospho-AKT</t> expression levels in the treated PD model. ELISA assay was performed with plasmalogen-loaded nanoparticles PL-C, which were dispersed at same total lipid concentration of 10 µM in the presence of 5 µM PACAP. f Kinetic changes of phospho-ERK expression in the treated PD model measured by ELISA assay with plasmalogen-loaded nanoparticles PL-C at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The data of ( d – f ) is presented as a ratio of the quantity of p-CREB, p-AKT or p-ERK expression (ng) per total protein (ng) in the treated group ( n = 3) and the quantity of p-CREB expression (ng) per total protein (ng) in the 6-OHDA group ( n = 3). n indicates the number of replicates per group and the error bars represent the standard deviation. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.
    Duoset Ic Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Phospho-Akt+(S473)+Pan+Specific+DuoSet+IC+ELISA/pm34238157-79-19-23
    Average 93 stars, based on 1 article reviews
    duoset ic elisa kit - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    R&D Systems Hematology p akt
    ( A ) The content of VEGF protein in the supernatant of BMSCs was determined by <t>ELISA.</t> * P <0.01, # P <0.05, △ P <0.01 ( n =15). ( B ) The content of IL-6 protein in each BMSC supernatant was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( C ) The content of Akt protein in BMSC lysates was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( D ) The content of <t>P-Akt</t> protein in each BMSC cohort was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15).
    P Akt, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Phospho-Akt+(S473)+Pan+Specific+DuoSet+IC+ELISA/pmc08493446-82-19-27
    Average 94 stars, based on 1 article reviews
    p akt - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    R&D Systems human mouse rat phospho akt s473 pan specific duoset ic elisa kit
    ( A ) The content of VEGF protein in the supernatant of BMSCs was determined by <t>ELISA.</t> * P <0.01, # P <0.05, △ P <0.01 ( n =15). ( B ) The content of IL-6 protein in each BMSC supernatant was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( C ) The content of Akt protein in BMSC lysates was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( D ) The content of <t>P-Akt</t> protein in each BMSC cohort was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15).
    Human Mouse Rat Phospho Akt S473 Pan Specific Duoset Ic Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Phospho-Akt+(S473)+Pan+Specific+DuoSet+IC+ELISA/pmc08152178-139-24-37
    Average 93 stars, based on 1 article reviews
    human mouse rat phospho akt s473 pan specific duoset ic elisa kit - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    R&D Systems phospho akt ser473 pan specific duoset ic elisa kits
    ( A ) The content of VEGF protein in the supernatant of BMSCs was determined by <t>ELISA.</t> * P <0.01, # P <0.05, △ P <0.01 ( n =15). ( B ) The content of IL-6 protein in each BMSC supernatant was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( C ) The content of Akt protein in BMSC lysates was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( D ) The content of <t>P-Akt</t> protein in each BMSC cohort was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15).
    Phospho Akt Ser473 Pan Specific Duoset Ic Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+akt+specific+elisa+kit/Phospho-ERK1+(T202%2FY204)%2FERK2+(T185%2FY187)+DuoSet+IC+ELISA/pmc07709950-189-9-0
    Average 94 stars, based on 1 article reviews
    phospho akt ser473 pan specific duoset ic elisa kits - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    a LNP cellular uptake measured by flow cytometry: Internalization of Rhodamine R18-labeled MO cubosomes (10 µM) in differentiated SH-SY5Y cells after 24 h of incubation (determined by FL2 fluorescence intensity). b Cellular uptake of PACAP: Internalization of PACAP-TAMRA (5 µM) in differentiated SH-SY5Y cells at different incubation times of 3 h, 6 h and 24 h (determined by FL2 fluorescence intensity). c Cellular uptake of LNP-PACAP: Internalization of LNP-PACAP-TAMRA by differentiated SH-SY5Y cells from 5 µM PACAP-TAMRA/10 µM LNPs mixture at different time points 3 h, 6 h and 24 h. The data of ( a – c ) was presented as a ratio of the mean intensity of FL2 in the treated group ( n = 3) and the mean intensity of FL2 in the RA/FBS(-) control group. d Kinetic changes of CREB phosphorylation in the PD model. The ELISA assay was performed with plasmalogen-loaded PL-C LNPs, which were dispersed at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The different incubation times were 0, 3 h, 6 h, and 24 h following 30 min 6-OHDA exposure. e Kinetics changes of phospho-AKT expression levels in the treated PD model. ELISA assay was performed with plasmalogen-loaded nanoparticles PL-C, which were dispersed at same total lipid concentration of 10 µM in the presence of 5 µM PACAP. f Kinetic changes of phospho-ERK expression in the treated PD model measured by ELISA assay with plasmalogen-loaded nanoparticles PL-C at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The data of ( d – f ) is presented as a ratio of the quantity of p-CREB, p-AKT or p-ERK expression (ng) per total protein (ng) in the treated group ( n = 3) and the quantity of p-CREB expression (ng) per total protein (ng) in the 6-OHDA group ( n = 3). n indicates the number of replicates per group and the error bars represent the standard deviation. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Journal: Communications Chemistry

    Article Title: Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies

    doi: 10.1038/s42004-023-01043-9

    Figure Lengend Snippet: a LNP cellular uptake measured by flow cytometry: Internalization of Rhodamine R18-labeled MO cubosomes (10 µM) in differentiated SH-SY5Y cells after 24 h of incubation (determined by FL2 fluorescence intensity). b Cellular uptake of PACAP: Internalization of PACAP-TAMRA (5 µM) in differentiated SH-SY5Y cells at different incubation times of 3 h, 6 h and 24 h (determined by FL2 fluorescence intensity). c Cellular uptake of LNP-PACAP: Internalization of LNP-PACAP-TAMRA by differentiated SH-SY5Y cells from 5 µM PACAP-TAMRA/10 µM LNPs mixture at different time points 3 h, 6 h and 24 h. The data of ( a – c ) was presented as a ratio of the mean intensity of FL2 in the treated group ( n = 3) and the mean intensity of FL2 in the RA/FBS(-) control group. d Kinetic changes of CREB phosphorylation in the PD model. The ELISA assay was performed with plasmalogen-loaded PL-C LNPs, which were dispersed at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The different incubation times were 0, 3 h, 6 h, and 24 h following 30 min 6-OHDA exposure. e Kinetics changes of phospho-AKT expression levels in the treated PD model. ELISA assay was performed with plasmalogen-loaded nanoparticles PL-C, which were dispersed at same total lipid concentration of 10 µM in the presence of 5 µM PACAP. f Kinetic changes of phospho-ERK expression in the treated PD model measured by ELISA assay with plasmalogen-loaded nanoparticles PL-C at total lipid concentration of 10 µM in the presence of 5 µM PACAP peptide. The data of ( d – f ) is presented as a ratio of the quantity of p-CREB, p-AKT or p-ERK expression (ng) per total protein (ng) in the treated group ( n = 3) and the quantity of p-CREB expression (ng) per total protein (ng) in the 6-OHDA group ( n = 3). n indicates the number of replicates per group and the error bars represent the standard deviation. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Article Snippet: DYC1018B-5, Bio-Techne Ltd./R&D Systems, UK), and Phospho-AKT (S473) Pan Specific DuoSet IC ELISA kits (Cat. #.

    Techniques: Flow Cytometry, Labeling, Incubation, Fluorescence, Enzyme-linked Immunosorbent Assay, Concentration Assay, Expressing, Standard Deviation

    ( A ) The content of VEGF protein in the supernatant of BMSCs was determined by ELISA. * P <0.01, # P <0.05, △ P <0.01 ( n =15). ( B ) The content of IL-6 protein in each BMSC supernatant was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( C ) The content of Akt protein in BMSC lysates was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( D ) The content of P-Akt protein in each BMSC cohort was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15).

    Journal: Bioscience Reports

    Article Title: Paracrine interleukin-8 affects mesenchymal stem cells through the Akt pathway and enhances human umbilical vein endothelial cell proliferation and migration

    doi: 10.1042/BSR20210198

    Figure Lengend Snippet: ( A ) The content of VEGF protein in the supernatant of BMSCs was determined by ELISA. * P <0.01, # P <0.05, △ P <0.01 ( n =15). ( B ) The content of IL-6 protein in each BMSC supernatant was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( C ) The content of Akt protein in BMSC lysates was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15). ( D ) The content of P-Akt protein in each BMSC cohort was determined by ELISA. * P <0.01, # P <0.01, △ P <0.01 ( n =15).

    Article Snippet: The BMSC lysates’ contents of Akt and phospho-Akt (P-Akt) in each group were determined by human-Akt (cat. no. DYC1775-5), P-Akt (cat. no. DYC887B-5), and ELISA kit (All R&D, MN, USA).

    Techniques: Enzyme-linked Immunosorbent Assay